This complex has been demonstrated to alleviate hypertension by inhibiting the secretion of pro-inflammatory factors, including monocyte chemotactic protein 1 (MCP-1) and interleukin-8 (IL-8), in human monocytes [127,146]. This evidence concerns the gene CCL2 and hypertensive disorder.